Vik Bajaj

Vik Bajaj, co-founder of Verily and Grail, is now steering Xaira Therapeutics, where he's leveraging AI to revolutionize drug development. He discusses how machine learning can streamline the drug discovery process by simulating biological systems to predict interactions. Bajaj highlights the necessity of robust genomic datasets and the integration of AI with biotechnology for greater insights. He explores exciting AI applications, addressing challenges while envisioning breakthroughs that could reshape the industry.